Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7.

Abstract

Since development of mucosal vaccines for the prevention of infectious diseases requires efficient antigen delivery; therefore, this research could be a new strategy for developing vaccine against E. coli O157:H7.